Open main menu
Search Ctrl + K
Free Trial
Loading...
G1 Therapeutics, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.GTHX
700 Park Offices Drive, Suite 200, Research Triangle Park, NC, 27709
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Prospectuses and Registrations
S-8 POS
Post-effective Amendment To An S-8 Filing.
18 Sep 24
25-NSE
Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.
18 Sep 24
S-8 POS
Post-effective Amendment To An S-8 Filing.
18 Sep 24
S-8 POS
Post-effective Amendment To An S-8 Filing.
18 Sep 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
18 Sep 24
S-8 POS
Post-effective Amendment To An S-8 Filing.
18 Sep 24
S-8 POS
Post-effective Amendment To An S-8 Filing.
18 Sep 24
Ownership
SC 13G/A
13 Nov 24
4
Murdock Terry L
18 Sep 24
4
Thomas Monica R.
18 Sep 24
4
Lee Jacks
18 Sep 24
4
Bailey John E. (jack) Jr.
18 Sep 24
4
Avagliano Mark
18 Sep 24
4
Malik Rajesh
18 Sep 24
News
8-K
Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modifications To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
18 Sep 24
8-K
Results Of Operations And Financial Condition
08 Aug 24
8-K
Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
07 Aug 24
8-K
Regulation Fd Disclosure
24 Jun 24
8-K
Submission Of Matters To A Vote Of Security Holders
14 Jun 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
01 May 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
22 Mar 24
Financials
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
01 May 24
10-K
Fiscal Year 2024
28 Feb 24
10-Q
Quarterly Filing
01 Nov 23
10-Q
Quarterly Filing
02 Aug 23
10-Q
Quarterly Filing
03 May 23
10-K
Fiscal Year 2022
01 Mar 23
Other
15-12G
Certification And Notice Of Termination Of Registration Under Section 12(g) Or Suspension Of Duty To File Reports.
30 Sep 24
SC 14D9/A
Amended Solicitation/recommendation Statement Under Section 14(d)(4).
18 Sep 24
SC 14D9/A
Amended Solicitation/recommendation Statement Under Section 14(d)(4).
10 Sep 24
SC 14D9/A
Amended Solicitation/recommendation Statement Under Section 14(d)(4).
05 Sep 24
SC 14D9
Solicitation/recommendation Statement Under Section 14(d)(4) Of The Exchange Act.
20 Aug 24
SC14D9C
Written Communication Relating To A Third Party Tender Offer.
08 Aug 24
SC14D9C
Written Communication Relating To A Third Party Tender Offer.
07 Aug 24
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
25 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
25 Apr 24
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
12 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
26 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
26 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 22